Back
Sarepta Therapeutics Stock Predictions
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$58.81
Seasonality Move:
15.14%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Sarepta Therapeutics Stock Forecast
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 32.1% based on the past 27 years of stock performance.
-
Sarepta Therapeutics has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
-
Is Sarepta Therapeutics Stock Undervalued?The current Sarepta Therapeutics [SRPT] share price is $62.47. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Sarepta Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 32.1% based on the past 27 years of stock performance.
Sarepta Therapeutics Stock Rating
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics overpriced?
-
Sarepta Therapeutics has risen higher in 13 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 48.15%
Sarepta Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com
52-Week Data
52-Week High:
173.25
52-Week Low:
60.70
Prediction Charts
Market Cap:
6.1B
Price in USD:
62.47
Volume:
3.8M
Beta:
1.09
Technical Analysis
SMA50:
100.16
SMA100:
110.81
SMA200:
123.02
52-Wk Change:
-50.81%
Stock Predictions
-
Is Sarepta Therapeutics stock public?Yes, Sarepta Therapeutics is a publicly traded company.
-
What is the Sarepta Therapeutics stock quote today?The Sarepta Therapeutics stock price is 62.47 USD today.
-
How to buy Sarepta Therapeutics stock online?You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-14 | 99.00 | 97.19 | 100.00 | 97.06 |
| Mar-17 | 97.35 | 101.35 | 103.32 | 97.35 |
| Mar-18 | 78.62 | 73.54 | 81.87 | 73.06 |
| Mar-19 | 75.18 | 79.97 | 80.98 | 75.13 |
| Mar-20 | 80.18 | 73.45 | 80.26 | 73.06 |
| Mar-21 | 73.32 | 74.10 | 75.50 | 73.05 |
| Mar-24 | 74.67 | 76.33 | 76.67 | 74.44 |
| Mar-25 | 76.13 | 73.61 | 76.26 | 72.17 |
| Mar-26 | 73.88 | 72.88 | 74.40 | 70.91 |
| Mar-27 | 72.98 | 71.81 | 73.95 | 71.25 |
| Mar-28 | 71.88 | 70.41 | 72.05 | 69.81 |
| Mar-31 | 65.90 | 63.82 | 67.47 | 62.50 |
| Apr-1 | 64.37 | 61.91 | 65.69 | 61.53 |
| Apr-2 | 61.69 | 62.47 | 64.23 | 60.70 |
Sarepta Therapeutics Earnings
Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Sarepta Therapeutics Forecast Revenue Growth
Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.